Penn expecting $467M windfall from COVID-19 vaccine royalty …
1 day ago · As part of the deal, pharmaceutical giant Pfizer is expected to chip in $170 million for the Penn royalties and $364 million towards the NIH royalties owed. As a company, BioNTech generated about $3.9 billion in revenue during 2023, down from $17.7 billion in 2022. BioNTech estimated 2024 revenue to be between $2.7 billion and $3.3 billion.
Penn to receive $467M under settlement with BioNTech over …
Dec 30, 2024 · BioNTech, in its filing, said Pfizer (NYSE: PFE) will reimburse it for $170 million of the Penn royalties and $364.5 million of royalties paid to the National Institutes of Health for 2020 to 2023 ...
BioNTech enters settlement with US agency, UPenn over COVID …
Dec 27, 2024 · (Reuters) -BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its...
Penn to receive $467M from BioNTech in COVID-19 vaccine …
Dec 31, 2024 · BioNTech also disclosed last week a settlement with the National Institutes of Health for $791.5 million, including $750 million in royalties for patents held by the U.S. government. Pfizer will reimburse BioNTech for $364.5 million for its share. As in the Penn settlement, BioNTech noted that the agreement is not an admission of liability.
Penn expecting $467M windfall from COVID-19 vaccine royalty …
5 days ago · The University of Pennsylvania expects to receive $467 million from a German COVID-19 vaccine manufacturer after the pair settled a lawsuit out of court in late December 2024.
BioNTech settles with NIH, Penn over COVID vaccine royalties
5 days ago · As for Penn, the university will get up to $467 million from BioNTech, the company revealed in a separate filing (PDF). That sum includes $400 million in royalties for 2020 to 2023, plus up to $15 ...
Penn expecting $467M from COVID-19 vaccine royalty dispute
5 days ago · Penn expecting $467M windfall from COVID-19 vaccine royalty dispute. ... The University of Pennsylvania and BioNTech declined to comment for this news story. BioNTech agreed to pay $400 million in royalties owed from between 2020 and 2023 to the university, plus another $15 million to fund BioNTech and University of Pennsylvania vaccine ...
BioNTech settles with U.S. agency, University of Pennsylvania over ...
Dec 27, 2024 · BioNTech reached settlements with the U.S. National Institutes of Health and the University of Pennyslvania over royalties related to its Covid-19 vaccine.
BioNTech to pay $467M in settlement agreement with University …
Dec 27, 2024 · Upon partial receipt of the Settlement Payment, Penn has agreed to dismiss with prejudice the litigation Penn filed against the Company and its former subsidiary, BioNTech RNA...
BioNTech Enters Into Settlements With NIH, UPenn Over COVID …
Dec 30, 2024 · The company “said on Friday it would pay $791.5 million to the U.S. agency to resolve a default notice.” Separately, BioNTech “will pay $467 million to the University of Pennsylvania (Penn), which has agreed to dismiss a lawsuit brought against the vaccine maker accusing it of underpaying royalties.”